GB1122957A - Substituted benzimidazoles and anthelmintic compositions containing them - Google Patents

Substituted benzimidazoles and anthelmintic compositions containing them

Info

Publication number
GB1122957A
GB1122957A GB2272366A GB2272366A GB1122957A GB 1122957 A GB1122957 A GB 1122957A GB 2272366 A GB2272366 A GB 2272366A GB 2272366 A GB2272366 A GB 2272366A GB 1122957 A GB1122957 A GB 1122957A
Authority
GB
United Kingdom
Prior art keywords
alkyl
carbon atoms
compounds
hydrogen
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2272366A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US533457A external-priority patent/US3336191A/en
Priority claimed from US540218A external-priority patent/US3401173A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of GB1122957A publication Critical patent/GB1122957A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Abstract

The invention comprises novel compounds of formula I <FORM:1122957/C2/1> where A is (1) an unsubstituted or methyl-substituted monocyclic 5-membered heterocyclic ring bonded to the carbonyl group through one of its carbon atoms, or (2) straight or branched chain alkyl having 2-10 carbon atoms; cycloalkyl or alkylcycloalkyl of 3-10 carbon atoms; straight or branched chain alkenyl of 3 to 10 carbon atoms; straight or branched chain alkynyl of 3-10 carbon atoms; naphthyl; alkylphenyl; or alkoxyphenyl; provided that when A is alkenyl or alkynyl the double or triple bond thereof is not conjugated with the C = X double bond; X is oxygen or sulphur; R is hydrogen, or alkyl or hydroxyalkyl having 1-10 carbon atoms, or benzyl; R1 is hydrogen or alkyl having 1-10 carbon atoms; and Y and Z are hydrogen, alkyl or alkoxy having 1-10 carbon atoms, trifluoromethyl, amino, mono- or di-alkylamino, cyano, acylamino, halo, hydroxy, nitro, alkylthio, carboxy, carbalkoxy, carbamoyl, or mono- or di-alkyl-carbamoyl, all of the undefined substituent alkyl groups having 1 to 4 carbon atoms therein; and pharmaceutically acceptable acid addition salts thereof. Compounds of formula I above may generally be prepared by condensing a 2-aminobenzimidazole with a compound A-CX-Cl, or by reacting cyanamide with an acid chloride in a basic solvent, and reacting the product with an o-phenylenediamine. Compounds in which Y or Z is amino are obtained by reduction of the corresponding nitro compound. Compounds in which R is alkyl, hydroxyalkyl or benzyl may be prepared by reacting 2-aminobenzimidazole with an acid chloride or also by alkylatng or benzylating the final product. When X is sulphur the compounds may be prepared by treating the corresponding compound wherein X is oxygen with phosphorus pentasulphide. When R1 is alkyl and R is hydrogen, the compounds may be obtained by treating o-phenylene diamine with an alkyl isothiocyanate, cyclizing the alkyl o-aminophenyl thiourea obtained, and treating the 2-alkylaminobenzimidazole produced with an acyl halide. Thiophen-2-carboxylic acid chloride and pyrrole 2-carboxylic acid chloride are prepared from the corresponding acid. Anthelmintic compositions which may be administered orally, e.g. as a sheep drench or bolus, or may be formulated into a feed supplement or animal food concentrate or may be added directly to the food, comprise as active ingredient a compound of formula I above.
GB2272366A 1965-06-07 1966-05-20 Substituted benzimidazoles and anthelmintic compositions containing them Expired GB1122957A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46208065A 1965-06-07 1965-06-07
US533457A US3336191A (en) 1966-03-11 1966-03-11 Anthelmintic 2-amidobenzimidazoles
US540218A US3401173A (en) 1966-04-05 1966-04-05 Heterocyclic acylaminobenzimidazoles

Publications (1)

Publication Number Publication Date
GB1122957A true GB1122957A (en) 1968-08-07

Family

ID=27412864

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2272366A Expired GB1122957A (en) 1965-06-07 1966-05-20 Substituted benzimidazoles and anthelmintic compositions containing them

Country Status (1)

Country Link
GB (1) GB1122957A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343894A1 (en) * 1988-05-24 1989-11-29 Pfizer Inc. Benzamide protease inhibitors
WO2004014905A1 (en) * 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
US7893267B2 (en) 2005-03-14 2011-02-22 High Point Pharmaceuticals, Llc Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343894A1 (en) * 1988-05-24 1989-11-29 Pfizer Inc. Benzamide protease inhibitors
WO2004014905A1 (en) * 2002-08-08 2004-02-19 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
US7138420B2 (en) 2002-08-08 2006-11-21 Boehringer Ingelheim Pharmaceuticals Inc. Substituted benzimidazole compounds
US7893267B2 (en) 2005-03-14 2011-02-22 High Point Pharmaceuticals, Llc Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
US8598353B2 (en) 2005-03-14 2013-12-03 High Point Pharmaceuticals, Llc Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors

Similar Documents

Publication Publication Date Title
GB1114069A (en) Benzimidazole derivatives and anthelmintic compositions containing them
KR920701167A (en) Pharmaceutically active compounds
IE34765L (en) Nitrofuryl-thienopyrimidines
US3846413A (en) New imines, their preparation and their pharmaceutical use
US3336191A (en) Anthelmintic 2-amidobenzimidazoles
GB966796A (en) Compositions containing substituted benzimidazoles
GB1122957A (en) Substituted benzimidazoles and anthelmintic compositions containing them
IT1206498B (en) AMIDINE DERIVATIVES OF 4-PHENYLMIDAZOLE 2-SUBSTITUTE PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE.
GB1153347A (en) Imidazole Derivatives, their preparation and Compositions containing them.
GB932256A (en) Diuretic compositions
US3819618A (en) Thiazolo(3,4-a)benzimidazoles
GB1327930A (en) 1,4-benzodiazepine derivatives
GB1466924A (en) Indazole derivatives
ES339158A1 (en) A novel imidazole derivative and a novel intermediate therefor
GB1321368A (en) Organo-phosphorus compounds useful for the control of helminths in warm-blooded animals
ES448593A1 (en) Antifungal 1-substituted benzimidazoles
GB1318859A (en) Imidazo-4,5-b-pyridine derivatives
GB1111957A (en) Improvements in or relating to anthelmintic compositions
GB1174760A (en) Hydantoin Derivatives
US3790590A (en) 2-amino-1,3,4-thiadiazole-5-carboxaldehyde oxime and 2-acetamido-1,3,4-thiadiazole-carbonitrile
GB1072735A (en) Chemotherapeutic compositions containing substituted benzimidazoles
GB989259A (en) Novel hydrazine derivatives and a process for the manufacture thereof
GB1270843A (en) Nitrofuran derivatives
GB1315243A (en) Triaza heterocyclic compounds
ES370991A1 (en) 3-carboxylic acid-amido-quinoxaline-di-n-oxides-(1 4) and their production